Zerrin Yiğit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zerrin Yiğit has a total of 220 co-authors. Here are the top co-authors by number of shared publications:
- Baris Okcun
Department of Cardiology, Istanbul University-Cerrahpasa, Institute of Cardiology , Cerrahpasa Mah., Org. Abdurrahman Nafiz Gurman Cd., Bina No. 24, Istanbul 34098
2 shared publications - Ece Yi̇ği̇t
Department of Internal Medicine, Medipol University Hospital, Faculty of Medicine, Istanbul Medipol University, 34893 Istanbul, Turkey
2 shared publications - Abdul Kerim Buğra
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL MEHMET AKİF ERSOY GÖĞÜS KALP VE DAMAR CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, KALP VE DAMAR CERRAHİSİ ANABİLİM DALI
1 shared publication - Abdullah Maşta1 shared publication
- Abdurrahim Çolak
Department of Cardiovascular Surgery, Atatürk University Faculty of Medicine, Erzurum, Türkiye
1 shared publication - Abdülkadir Ercan
Department of Cardiovascular Surgery, Istinye University Faculty of Medicine, Istanbul, Türkiye
1 shared publication
Latest Publications
- 23 March 2026
- Published by Academician Publishing
- p. 239-248
Miyokart Canlılığı
- Open Access
- 2 July 2021
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 49 (5) , 357-367
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
Heart failure (HF) is a growing public health problem with high morbidity and mortality. Recently, angiotensin receptor neprilysin inhibitor (ARNi) has emerged as a promising treatment for HF with reduced ejection fraction (HFrEF). Here, we shared our experience with the use of ARNi in HFrEF from multiple centers in Turkey. The ARNi-TR is a multicenter, noninterventional, retrospective, observational study. Overall, 779 patients with HF from 22 centers in Turkey who were prescribed sacubitril/valsartan were examined. Initial clinical status, biochemical and echocardiographic parameters, and New York Heart Association functional class (NYHA-FC) values were compared with follow-up values after 1 year of ARNi use. In addition, the effect of ARNi on number of annual hospitalizations was investigated, and the patients were divided into 2 groups, depending on whether ARNi was initiated at hospitalization or under outpatient clinic control. N-terminal pro-brain natriuretic peptide (NT-proBNP), left-ventricle ejection fraction (LV-EF), and NYHA-FC values improved significantly in both groups (all parameters, p<0.001) within 1-year follow-up. In both groups, a decrease in hemoglobin A1c (HbA1c) values was observed in ARNi use (p<0.001), and a decrease in daily diuretic doses and hospitalizations owing to HF were observed after ARNi use (all comparisons, p<0.001). Hypertension (16.9%) was the most common side effect in patients using ARN. The ARNi-TR study offers comprehensive real-life data for patients using ARNi in Turkey. The use of ARNi has shown significant improvements in FC, NT-proBNP, HbA1c levels, and LV-EF. Likewise, reductions in the number of annual hospitalizations and daily furosemide doses for HF were seen in this study.
- 2 July 2021
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 49 (5) , 357-367
Open AccessAngiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
Heart failure (HF) is a growing public health problem with high morbidity and mortality. Recently, angiotensin receptor neprilysin inhibitor (ARNi) has emerged as a promising treatment for HF with reduced ejection fraction (HFrEF). Here, we shared our experience with the use of ARNi in HFrEF from multiple centers in Turkey. The ARNi-TR is a multicenter, noninterventional, retrospective, observational study. Overall, 779 patients with HF from 22 centers in Turkey who were prescribed sacubitril/valsartan were examined. Initial clinical status, biochemical and echocardiographic parameters, and New York Heart Association functional class (NYHA-FC) values were compared with follow-up values after 1 year of ARNi use. In addition, the effect of ARNi on number of annual hospitalizations was investigated, and the patients were divided into 2 groups, depending on whether ARNi was initiated at hospitalization or under outpatient clinic control. N-terminal pro-brain natriuretic peptide (NT-proBNP), left-ventricle ejection fraction (LV-EF), and NYHA-FC values improved significantly in both groups (all parameters, p<0.001) within 1-year follow-up. In both groups, a decrease in hemoglobin A1c (HbA1c) values was observed in ARNi use (p<0.001), and a decrease in daily diuretic doses and hospitalizations owing to HF were observed after ARNi use (all comparisons, p<0.001). Hypertension (16.9%) was the most common side effect in patients using ARN. The ARNi-TR study offers comprehensive real-life data for patients using ARNi in Turkey. The use of ARNi has shown significant improvements in FC, NT-proBNP, HbA1c levels, and LV-EF. Likewise, reductions in the number of annual hospitalizations and daily furosemide doses for HF were seen in this study.
- 16 April 2021
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
How much do the Patients with Acute Myocardial Infarction Know about Chest Pain, Thrombolytic Therapy, and Other Factors Affecting the Treatment Time in the Emergency Room?
Background: Treatment time in the emergency room for acute myocardial infarction is very important and can be life-saving if one understands the importance of a patient’s chest pain. Objetice: The aim of this study is to evaluate how much patients entering the emergency room due to acute myocardial infection (AMI) know about chest pain and thrombolytic therapy. Materials and Methods: One hundred fifty patients (126 males,14 females) from three different institutes with complaints of chest pain were randomly chosen [...] Abstract Background: Treatment time in the emergency room for acute myocardial infarction is very important and can be life-saving if one understands the importance of a patient’s chest pain. Objetice: The aim of this study is to evaluate how much patients entering the emergency room due to acute myocardial infection (AMI) know about chest pain and thrombolytic therapy. Materials and Methods: One hundred fifty patients (126 males,14 females) from three different institutes with complaints of chest pain were randomly chosen
- 16 April 2021
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
How much do the Patients with Acute Myocardial Infarction Know about Chest Pain, Thrombolytic Therapy, and Other Factors Affecting the Treatment Time in the Emergency Room?
Background: Treatment time in the emergency room for acute myocardial infarction is very important and can be life-saving if one understands the importance of a patient’s chest pain. Objetice: The aim of this study is to evaluate how much patients entering the emergency room due to acute myocardial infection (AMI) know about chest pain and thrombolytic therapy. Materials and Methods: One hundred fifty patients (126 males,14 females) from three different institutes with complaints of chest pain were randomly chosen [...] Abstract Background: Treatment time in the emergency room for acute myocardial infarction is very important and can be life-saving if one understands the importance of a patient’s chest pain. Objetice: The aim of this study is to evaluate how much patients entering the emergency room due to acute myocardial infection (AMI) know about chest pain and thrombolytic therapy. Materials and Methods: One hundred fifty patients (126 males,14 females) from three different institutes with complaints of chest pain were randomly chosen
- Open Access
- 4 November 2020
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (11)
Changes in pentraxin 3 and oxidative parameters during coronary bypass grafting and factors affecting postoperative atrial fibrillation
Objective: The performance of coronary bypass grafting (CBG) induces a type of subclinical systemic inflammatory response syndrome. The present study was performed to examine the changes in pentraxin 3 (PTX3) and oxidative parameters during cross-clamping in patients undergoing CBG. We also examined factors affecting the development of postoperative atrial fibrillation (POAF). Method: This study involved 40 patients who underwent elective on-pump CBG (33 men, 7 women; mean age, 60.8 ± 8.0 years). Blood specimens were drawn before anaesthesia and after aortic cross-clamping. POAF was detected by analysing the rhythm records of telemetry units for 96 hours postoperatively. Results: The mean PTX3 concentration prior to surgery was 176.3 ± 148.4 pg/mL. After cross-clamping, it increased to 947.7 ± 377.2 pg/mL. The increase was statistically significant. Twelve patients had POAF. The leucocyte count and change in the oxidative stress index were significantly higher in patients without than with POAF. Although the increase in PTX3 was higher in patients without POAF, the difference was not statistically significant. Conclusion: The PTX3 concentration significantly increases during CBG. A significant change in the oxidative stress index and a more intense increase in the PTX3 concentration were seen in patients without POAF.
- 4 November 2020
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (11)
Open AccessChanges in pentraxin 3 and oxidative parameters during coronary bypass grafting and factors affecting postoperative atrial fibrillation
Objective: The performance of coronary bypass grafting (CBG) induces a type of subclinical systemic inflammatory response syndrome. The present study was performed to examine the changes in pentraxin 3 (PTX3) and oxidative parameters during cross-clamping in patients undergoing CBG. We also examined factors affecting the development of postoperative atrial fibrillation (POAF). Method: This study involved 40 patients who underwent elective on-pump CBG (33 men, 7 women; mean age, 60.8 ± 8.0 years). Blood specimens were drawn before anaesthesia and after aortic cross-clamping. POAF was detected by analysing the rhythm records of telemetry units for 96 hours postoperatively. Results: The mean PTX3 concentration prior to surgery was 176.3 ± 148.4 pg/mL. After cross-clamping, it increased to 947.7 ± 377.2 pg/mL. The increase was statistically significant. Twelve patients had POAF. The leucocyte count and change in the oxidative stress index were significantly higher in patients without than with POAF. Although the increase in PTX3 was higher in patients without POAF, the difference was not statistically significant. Conclusion: The PTX3 concentration significantly increases during CBG. A significant change in the oxidative stress index and a more intense increase in the PTX3 concentration were seen in patients without POAF.
- Open Access
- 28 April 2019
- Published by Mersin Universitesi Saglik Bilimleri Dergisi in Mersin Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 12 (1) , 22-31
Evaluation of healty lifestyle behaviours of patients with cardiovascular heart disease
Amaç: Kardiyovasküler hastalıkların risk faktörlerini azaltmak için bireylerin sağlıklı yaşam davranışlarını kazanmaları gerekmektedir. Bu araştırma, koroner arter hastalık tanısı almış bireylerin sağlıklı yaşam biçimi davranışlarının belirlenmesi amacıyla tanımlayıcı tipte kesitsel olarak yapılmıştır. Yöntem: Araştırmanın evrenini 1 Ocak– 31 Mart 2017 tarihleri arasında, bir araştırma hastanesinin kardiyoloji polikliniklerinde takip edilen, koroner arter hastalık tanısı almış, yaş ortalaması 57.1± 13.2 yıl (minimum 18-maksimum 80) olan hastalar oluşturmuştur. Araştırmanın örneklemine araştırmaya katılmayı kabul eden ve rastgele örneklem yöntemi ile seçilen 351 hasta alınmıştır. Veriler, hastaların sosyo-demografik özelliklerine ilişkin “Tanıtıcı Bilgi Formu” ve “Sağlıklı Yaşam Biçimi Davranışları Ölçeği II” kullanılarak toplanmıştır. Verilerin değerlendirilmesinde aritmetik ortalama, standart sapma, minimum, maksimum ve yüzde parametreleri kullanılmıştır. Verilerin normal dağılıma uygunluğu Kolmogorov Smirnov testiyle yapılmıştır, anlamlılık değerleri >0.05 olduğundan ileri düzey çözümlemelerde parametrik olan testler kullanılmıştır. Parametrik olan testlerden iki bağımsız değişken için bağımsız örneklem t testi, ikiden fazla bağımsız değişken için One-Way ANOVA testi kullanılmıştır. Bulgular: Araştırmadan elde edilen bulgulara göre “Sağlıklı Yaşam Biçimi Davranışları Ölçeği II” ölçeği toplam puan ortalaması 132.75± 3.37’dir. Cinsiyete göre ölçeğin alt boyutlarının puan ortalamaları karşılaştırıldığında, erkeklerin manevi gelişim, kişiler arası ilişkiler, stres yönetimi puan ortalamalarının daha yüksek, beslenme puan ortalamasının daha düşük olduğu (p<0.05) belirlenmiştir. Fiziksel aktivite ve manevi gelişim puan ortalamalarının yaş arttıkça azaldığı (p<0.05), fiziksel aktivite puan ortalamasının eğitim düzeyi yükseldikçe arttığı saptanmıştır (p<0.05). Sonuç: Bu çalışmada, katılımcıların en düşük ve en yüksek puan ortalamalarını aldıkları alt boyutlar sırasıyla, fiziksel aktivite ve kişiler arası ilişkilerdir. Fiziksel aktivite alt boyutu ortalama puanının yaş ile ters, eğitim düzeyi ile doğru orantılı olarak arttığı belirlenmiştir.
- 28 April 2019
- Published by Mersin Universitesi Saglik Bilimleri Dergisi in Mersin Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 12 (1) , 22-31
Open AccessEvaluation of healty lifestyle behaviours of patients with cardiovascular heart disease
Amaç: Kardiyovasküler hastalıkların risk faktörlerini azaltmak için bireylerin sağlıklı yaşam davranışlarını kazanmaları gerekmektedir. Bu araştırma, koroner arter hastalık tanısı almış bireylerin sağlıklı yaşam biçimi davranışlarının belirlenmesi amacıyla tanımlayıcı tipte kesitsel olarak yapılmıştır. Yöntem: Araştırmanın evrenini 1 Ocak– 31 Mart 2017 tarihleri arasında, bir araştırma hastanesinin kardiyoloji polikliniklerinde takip edilen, koroner arter hastalık tanısı almış, yaş ortalaması 57.1± 13.2 yıl (minimum 18-maksimum 80) olan hastalar oluşturmuştur. Araştırmanın örneklemine araştırmaya katılmayı kabul eden ve rastgele örneklem yöntemi ile seçilen 351 hasta alınmıştır. Veriler, hastaların sosyo-demografik özelliklerine ilişkin “Tanıtıcı Bilgi Formu” ve “Sağlıklı Yaşam Biçimi Davranışları Ölçeği II” kullanılarak toplanmıştır. Verilerin değerlendirilmesinde aritmetik ortalama, standart sapma, minimum, maksimum ve yüzde parametreleri kullanılmıştır. Verilerin normal dağılıma uygunluğu Kolmogorov Smirnov testiyle yapılmıştır, anlamlılık değerleri >0.05 olduğundan ileri düzey çözümlemelerde parametrik olan testler kullanılmıştır. Parametrik olan testlerden iki bağımsız değişken için bağımsız örneklem t testi, ikiden fazla bağımsız değişken için One-Way ANOVA testi kullanılmıştır. Bulgular: Araştırmadan elde edilen bulgulara göre “Sağlıklı Yaşam Biçimi Davranışları Ölçeği II” ölçeği toplam puan ortalaması 132.75± 3.37’dir. Cinsiyete göre ölçeğin alt boyutlarının puan ortalamaları karşılaştırıldığında, erkeklerin manevi gelişim, kişiler arası ilişkiler, stres yönetimi puan ortalamalarının daha yüksek, beslenme puan ortalamasının daha düşük olduğu (p<0.05) belirlenmiştir. Fiziksel aktivite ve manevi gelişim puan ortalamalarının yaş arttıkça azaldığı (p<0.05), fiziksel aktivite puan ortalamasının eğitim düzeyi yükseldikçe arttığı saptanmıştır (p<0.05). Sonuç: Bu çalışmada, katılımcıların en düşük ve en yüksek puan ortalamalarını aldıkları alt boyutlar sırasıyla, fiziksel aktivite ve kişiler arası ilişkilerdir. Fiziksel aktivite alt boyutu ortalama puanının yaş ile ters, eğitim düzeyi ile doğru orantılı olarak arttığı belirlenmiştir.
- 26 April 2019
- Published by Wiley in Pediatric Pulmonology
- Vol. 54 (7) , 1002-1011
Effects of core stabilization exercises on pulmonary function, respiratory muscle strength, and functional capacity in adolescents with substance use disorder: Randomized controlled trial
Background: Adolescent substance abuse is a serious and growing problem worldwide. The aim of this study was to investigate the effects of core stabilization exercises on pulmonary function, respiratory muscle strength, and functional capacity in adolescents with substance use disorder (SUD).Methods: This was a prospective randomized controlled trial. A total of 49 adolescent male patients with SUD were randomly assigned to either the exercise group (n = 25; mean age 16.6 years) or the control group (n = 24; mean age 16.7 years), for 6 weeks. All participants underwent a medical and behavioral therapy program 5 days a week for 6 weeks. The exercise group received five core stabilization exercises combined with deep breathing as a group training for 45 to 60 minutes, twice a week for 6 weeks, and the control group received recreational activities in addition to the usual care for 45 to 60 minutes, twice a week for 6 weeks. Spirometry, maximal inspiratory and expiratory pressures, and the 6‐minute walk test were performed and measured at baseline and after training.Results: There were significant improvements in maximal inspiratory pressure (24.16 cm H2O; P < 0.0001), maximal expiratory pressure (30.28 cm H2O; P < 0.0001), forced vital capacity (5.80% predicted, P < 0.0001), forced expiratory volume in 1 second (7.34% predicted; P = 0.002), peak expiratory flow (13.32% predicted; P = 0.0003), forced expiratory flow 25%‐75% (11.84% predicted; P = 0.027), and the 6‐minute walking distance (65.84 m; P < 0.0001) in the exercise group compared with the control group.Conclusions: Core stabilization exercise can improve pulmonary function, respiratory muscle strength, and functional capacity in adolescents with SUD.
- 26 April 2019
- Published by Wiley in Pediatric Pulmonology
- Vol. 54 (7) , 1002-1011
Effects of core stabilization exercises on pulmonary function, respiratory muscle strength, and functional capacity in adolescents with substance use disorder: Randomized controlled trial
Background: Adolescent substance abuse is a serious and growing problem worldwide. The aim of this study was to investigate the effects of core stabilization exercises on pulmonary function, respiratory muscle strength, and functional capacity in adolescents with substance use disorder (SUD).Methods: This was a prospective randomized controlled trial. A total of 49 adolescent male patients with SUD were randomly assigned to either the exercise group (n = 25; mean age 16.6 years) or the control group (n = 24; mean age 16.7 years), for 6 weeks. All participants underwent a medical and behavioral therapy program 5 days a week for 6 weeks. The exercise group received five core stabilization exercises combined with deep breathing as a group training for 45 to 60 minutes, twice a week for 6 weeks, and the control group received recreational activities in addition to the usual care for 45 to 60 minutes, twice a week for 6 weeks. Spirometry, maximal inspiratory and expiratory pressures, and the 6‐minute walk test were performed and measured at baseline and after training.Results: There were significant improvements in maximal inspiratory pressure (24.16 cm H2O; P < 0.0001), maximal expiratory pressure (30.28 cm H2O; P < 0.0001), forced vital capacity (5.80% predicted, P < 0.0001), forced expiratory volume in 1 second (7.34% predicted; P = 0.002), peak expiratory flow (13.32% predicted; P = 0.0003), forced expiratory flow 25%‐75% (11.84% predicted; P = 0.027), and the 6‐minute walking distance (65.84 m; P < 0.0001) in the exercise group compared with the control group.Conclusions: Core stabilization exercise can improve pulmonary function, respiratory muscle strength, and functional capacity in adolescents with SUD.
- Open Access
- 30 September 2003
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 8 (4) , 308-312
The Effect of Exercise to P Wave Dispersion and Its Evaluation as a Predictor of Atrial Fibrillation
Prolongation of P wave time and increase of its dispersion as an independent predictor of atrial fibrillation. In patients with paroxysmal atrial fibrillation (PAF) as in healthy people, exercise augments sympathetic activity and therefore can cause the development of atrial fibrillation. The aim of this study is to evaluate the effect of exercise on P wave dispersion and to predict the development of atrial fibrillation. One hundred and ninety-eight patients (93 women, 105 men, mean age: 59.05 +/- 11.01 years) having the diagnosis of PAF were included in the study. The left atrial diameter of all these patients was more than 4.0 cm. One hundred and fifty-five patients (72 females, 83 males, mean age: 58.41 +/- 10.79 years), with left atrial diameter more than 4.0 cm and without PAF were taken as control group. Symptom limited exercise test with modified Bruce protocol was performed on all patients. Rest, maximum exercise and recovery, and first, third, and fifth-minute 12-derivation ECG was taken in all patients. The velocity of ECG was adjusted to 50 mm/s; shortest and largest P wave durations were measured and P wave dispersion was calculated. The mean left atrial diameter was 4.41 +/- 0.58 cm in PAF patients and 4.38 +/- 0.48 cm in control group. No differences were found between PAF patients with the controls in exercise time (10.38 +/- 2.93 vs 10.81 +/- 2.75 minutes); METs (6.98 +/- 1.72 vs 7.28 +/- 1.75 minutes); resting heart rate (79.13 +/- 14.86 vs 79.69 +/- 10.43 bpm); peak heart rate (146.83 +/- 23.21 vs 146.94 +/- 16.13 bpm). Maximum exercise P wave duration and P wave dispersion were greater than the rest measurements in PAF group (respectively P < 0.0001 and P = 0.0004). In PAF patients, P wave dispersion is significantly longer at rest, maximum exercise and recovery time than in a control group without PAF.
- 30 September 2003
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 8 (4) , 308-312
Open AccessThe Effect of Exercise to P Wave Dispersion and Its Evaluation as a Predictor of Atrial Fibrillation
Prolongation of P wave time and increase of its dispersion as an independent predictor of atrial fibrillation. In patients with paroxysmal atrial fibrillation (PAF) as in healthy people, exercise augments sympathetic activity and therefore can cause the development of atrial fibrillation. The aim of this study is to evaluate the effect of exercise on P wave dispersion and to predict the development of atrial fibrillation. One hundred and ninety-eight patients (93 women, 105 men, mean age: 59.05 +/- 11.01 years) having the diagnosis of PAF were included in the study. The left atrial diameter of all these patients was more than 4.0 cm. One hundred and fifty-five patients (72 females, 83 males, mean age: 58.41 +/- 10.79 years), with left atrial diameter more than 4.0 cm and without PAF were taken as control group. Symptom limited exercise test with modified Bruce protocol was performed on all patients. Rest, maximum exercise and recovery, and first, third, and fifth-minute 12-derivation ECG was taken in all patients. The velocity of ECG was adjusted to 50 mm/s; shortest and largest P wave durations were measured and P wave dispersion was calculated. The mean left atrial diameter was 4.41 +/- 0.58 cm in PAF patients and 4.38 +/- 0.48 cm in control group. No differences were found between PAF patients with the controls in exercise time (10.38 +/- 2.93 vs 10.81 +/- 2.75 minutes); METs (6.98 +/- 1.72 vs 7.28 +/- 1.75 minutes); resting heart rate (79.13 +/- 14.86 vs 79.69 +/- 10.43 bpm); peak heart rate (146.83 +/- 23.21 vs 146.94 +/- 16.13 bpm). Maximum exercise P wave duration and P wave dispersion were greater than the rest measurements in PAF group (respectively P < 0.0001 and P = 0.0004). In PAF patients, P wave dispersion is significantly longer at rest, maximum exercise and recovery time than in a control group without PAF.